Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates “Kalki AD 2898”: A mythological sci-fi spectacle set to transform cinema As “Kalki AD 2898,” the most anticipated pan-Indian release, gears up for its global debut tomorrow, it has… byPallavi MadhirajuJune 26, 2024